ArticleFrontiers in oncology2022

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma.

Yujun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.